Severity Assessment and Early Management of Acute Pancreatitis

Initial 24‑Hour Severity Assessment

Calculate the BISAP score within the first 24 hours using five bedside variables (elevated BUN, altered mental status, presence of SIRS, age > 60 years, and pleural effusion). The World Journal of Emergency Surgery recommends this rapid assessment. 2
A BISAP score ≥ 2 identifies patients at high risk for severe acute pancreatitis and signals the need for ICU‑level care. The score shows an area‑under‑the‑curve of ≈ 0.80 for severe disease and ≈ 0.93 for predicting organ failure. 1
BISAP predicts increased mortality risk before organ failure develops, unlike traditional 48‑hour scores. 2
The diagnostic performance of BISAP is comparable to APACHE‑II (sensitivity ≈ 70‑74 %, specificity ≈ 86‑90 %) while being far simpler to compute at the bedside. 2

Obtain admission labs including CRP, hematocrit, and BUN. Elevated hematocrit independently predicts pancreatic necrosis, and elevated BUN independently predicts mortality. 1

Any evidence of pulmonary, circulatory, or renal failure constitutes severe disease regardless of scoring results. This clinical judgment supersedes all scores. 3

If BISAP is high or the clinical picture is equivocal, calculate the APACHE‑II score for ongoing monitoring. The American Society of Critical Care recommends this approach. 3
APACHE‑II ≥ 8 defines severe acute pancreatitis; a threshold of ≥ 6 yields ≈ 95 % sensitivity for complications (though positive predictive value is modest). 1
Repeat APACHE‑II daily to track disease trajectory. 3
Measure CRP on day 3; a markedly elevated CRP indicates severe disease, and a peak CRP in the first four days that is substantially high predicts severity with ~80 % accuracy. 3

Ranson score ≥ 3 suggests severe disease (sensitivity ≈ 75‑87 %, specificity ≈ 68‑78 %, PPV ≈ 29‑49 %). Reserve its use for cases where other assessments are inconclusive. 3
Glasgow score ≥ 3 also denotes severe disease, validated in UK cohorts with 70‑80 % accuracy. 3

Perform contrast‑enhanced CT with CTSI calculation in patients predicted to have severe disease, but not before day 3 to avoid underestimation of necrosis. The World Journal of Emergency Surgery endorses this timing. 2
CTSI ranges from 0‑10; a score ≥ 3 indicates severe disease, while high scores (7‑10) are associated with very high morbidity (~92 %) and notable mortality (~17 %). 4

BISAP is preferred over traditional 48‑hour scores (Ranson, Glasgow) because it can be completed within 24 hours without loss of accuracy. 2
Clinical assessment alone misclassifies roughly half of patients, underscoring the necessity of objective scoring. 3
APACHE‑II remains the gold‑standard for ongoing monitoring despite its complexity, offering the highest predictive accuracy for mortality among the scores discussed. 1

BISAP ≥ 2 mandates immediate transfer to an intensive‑care setting (ideally within 24 hours; most transfers occur within 72 hours). 4
Prophylactic antibiotics are not recommended for any severity level (Grade 1A evidence). They provide no mortality or morbidity benefit in sterile necrosis and should be reserved for documented infected necrosis. [2][4]
Procalcitonin is a highly sensitive marker for pancreatic infection; low levels strongly predict the absence of infected necrosis. [2][4]

Do not rely on a single scoring system; combine BISAP with CRP trends and clinical organ‑failure assessment for comprehensive risk stratification. [4][3]
Do not postpone aggressive management while awaiting 48‑hour scores in patients with high BISAP or clear clinical severity. [4][3]
Recognize that positive predictive values for scores such as Ranson are modest; many patients classified as severe may recover uneventfully, but this should not deter appropriate escalation of care. [4][3]
Continuously monitor for the development of organ failure, as its occurrence definitively defines severe disease and overrides all scoring systems. [1][3]